MEDP
Undervalued by 63.8% based on the discounted cash flow analysis.
Market cap | $8.57 Billion |
---|---|
Enterprise Value | $8.26 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $13.06 |
Beta | 1.48 |
Outstanding Shares | 30,387,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 21.77 |
---|---|
PEG | 186.02 |
Price to Sales | 4.26 |
Price to Book Ratio | 15.7 |
Enterprise Value to Revenue | 3.83 |
Enterprise Value to EBIT | 17.55 |
Enterprise Value to Net Income | 19 |
Total Debt to Enterprise | 0.02 |
Debt to Equity | 0.34 |
No data
No data